期刊文献+

伴血小板增多的骨髓增生异常综合征伴环形铁粒幼细胞增多2例 被引量:3

下载PDF
导出
摘要 骨髓增生异常综合征/骨髓增殖性肿瘤(MDS/MPN)表现为既有血细胞的增殖,又有血细胞病态造血。MDS伴有环形铁粒幼细胞增多(RARS),同时伴有血小板(PLT)增多,即MDSRARS-T归入MDS/MPN不能分类(MDS/MPN-U)中,MDSRARS-T患者白细胞(WBC)、PLT多正常,但有少数患者PLT可增多,有的可≥600×109L-1。MDS-RARS-T患者临床表现类似特发性PLT增多症(ET),可发生血栓或其他并发症。本研究旨在观察MDS-RARS-T患者临床及形态学。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2014年第21期6216-6217,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献4

二级参考文献32

  • 1卢兴国,马顺高.骨髓增生异常/骨髓增殖性疾病形态学和分子病理[J].检验医学,2005,20(2):165-167. 被引量:6
  • 2朱平.骨髓增殖性疾病JAK2基因突变的临床意义[J].中华医学杂志,2006,86(32):2243-2245. 被引量:14
  • 3Germing U, Gattermann N, Strupp C, et al. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes:a retrospective analysis of 1600 patients. Leu Res, 2000, 24:983-992.
  • 4Hasle H. Myelodysplastic and myeloproliferative disorder in children. Curt Opin Pediatr, 2007, 19 : 1-8.
  • 5James C, Ugo V, LE Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 2005, 434 : 1144-1148.
  • 6Jones AV, Kreil S, Zoi K, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood, 2005,106 : 2162-2168.
  • 7Jelinek J, Oki Y, Gharibyan V, et al. JAK2 mutation 1849G >T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryoeytic leukemia. Blood, 2005,106: 3370-3373.
  • 8Jafl'e ES, Harris NL, Stein H, et al. WHO classification: turnouts of haematopoietic and lymphoid tissues. Lyon: IARC Press. 2001:17-44.
  • 9Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumors Haematopoietic and Lymphoid Tissues. France Lyon: IARC. 2008 : 109 - 138.
  • 10Greenberg PL, Young NS, Gattermann N. Myelodysplastic syndromes. Hematology Am Soc Hematol Educ Program, 2002;136 - 161.

共引文献31

同被引文献25

  • 1Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumors of haematopoietic and lymphoid tissues [ M ]. Lyon : IARC Press ,2008:75 - 86.
  • 2Ghman M, Vltdeanu AM, Radesi S. The implications of revised WHO classification ( 2008 ) of chronic myeloid neoplasms [ J ]. Rom J Intern Med,2011,49( 1 ) :25 -30.
  • 3Ceesay MM,Lea NC, Ingram W. The JAK2 V617F mutation is rare in RARS but common in RARS -T[ J]. Leukemia,2006,20( 11 ) : 2060 - 2061.
  • 4Mohamed M. Refractory anemia with ring sideroblasts associated with thrombocytosis( RARS - T) [ J]. Blood,2014,123 (3) :314.
  • 5Szpurka H,Jankowska AM, Makishima H, et al. Spectrum of muta- tions in RARS - T patients includes TET2 and ASXL1 mutations [J]. Leuk Res,2010,34(8) :969 -973.
  • 6Adds L, Fenaux P. Immunomodulating drugs in myelodysplastic syndromes [J]. Hematol Am Soc Hematol Educ Program,2011,2 : 556 - 560.
  • 7Brosus J, Alpermann T, Wulfert M, et al. Age, JAK2 (V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombo- cytosis [ J]. Leukemia,2013,27 (9) : 1826 - 1831.
  • 8以WHO分型标准诊断的435例原发性骨髓增生异常综合征预后积分系统研究[J].中华内科杂志,2009,48(8):633-637. 被引量:6
  • 9刘丹丹,吴德沛.细胞形态学检查诊断骨髓增生异常综合征临床意义[J].中国实用内科杂志,2010,30(5):398-401. 被引量:20
  • 10季鸥,沈群,林琳,章亚成,季建敏,吴萸,陈健一,朱光荣,孔祥图,夏雯,姜鹏君.血小板明显波动的难治性贫血伴环状铁粒幼细胞增多的临床与生物学特征[J].中国实验血液学杂志,2010,18(4):1036-1041. 被引量:4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部